Bacterioferritin of Magnetospirillum gryphiswaldense Is a Heterotetraeicosameric Complex Composed of Functionally Distinct Subunits but Is Not Involved in Magnetite Biomineralization

Magnetotactic bacteria like Magnetospirillum gryphiswaldense are able to orient along magnetic field lines due to the intracellular formation of magnetite nanoparticles. Biomineralization of magnetite has been suggested to require a yet-unknown ferritin-like ferrihydrite component. Here, we report the identification of a bacterioferritin as the source of ferrihydrite in M. gryphiswaldense and show that, contrary to previous reports, bacterioferritin is not involved in magnetite biomineralization but required for oxidative stress resistance. Additionally, we show that bacterioferritin of M. gryphiswaldense is an unusual member of the bacterioferritin subfamily as it is composed of two functionally distinct subunits. Thus, our findings extend our understanding of the bacterioferritin subfamily and also solve a longstanding question about the magnetite biomineralization pathway.

I ron is essential for almost all organisms. Because of its versatile biochemical properties, it serves as a cofactor in a multitude of biochemical reactions, including respiration, photosynthesis, or DNA synthesis (1). However, excess iron can be toxic due to its ability to increase the formation of reactive oxygen species via the Fenton reaction (2). To avoid iron-mediated toxicity, bacteria use regulatory sensor proteins (e.g., ferric uptake regulator [Fur]) to determine intracellular iron concentrations and transcriptionally control genes involved in the import, efflux, and metabolism of iron (3). Additionally, cells employ proteins of the ferritin-like superfamily to store excess iron as an inert iron mineral phase and thus prevent Fenton chemistry (2). Ferritin-like proteins with iron storage capability are found in the ferritin (Ftn), heme-containing bacterioferritin (Bfr), archaeoferritin (Afr), and DNA-binding proteins from starved cells (Dps) or Dps-like subfamilies (4)(5)(6). All of these proteins share a four-helical bundle structural motif and are able to self-assemble into sphere-shaped hollow tetraeicosameric (Ftn, Bfr, and Afr) or dodecameric (Dps and Dps-like) nanocages that engulf an iron mineral core (4). Iron mineralization in the interior of the nanocages is catalyzed by a ferroxidase center (FC) which is formed by dinuclear metal ion binding sites in the center of each Ftn and Bfr subunit or at subunit interphases in Dps proteins (7,8). Most iron-storing ferritin-like proteins form homooligomeric shells and thus have a fixed number of FCs per nanocage. Vertebrate ferritins, however, are heterooligomeric assemblies. In humans, for example, ferritin is composed of heavy (H)-and light (L)-chain ferritins which share only 55% sequence similarity and have different functionalities (9). While H-ferritin provides the FC residues, L-ferritin is thought to enhance oligomer stability and iron influx into the nanocage (10).
A rather unusual role of ferritin-like proteins was proposed for magnetotactic bacteria (MTB) (11). In Magnetospirillum species, a ferritin-like component was found to play a major role in the intracellular biomineralization pathway of membrane-enclosed ferrimagnetic magnetite [Fe 2ϩ (Fe 3ϩ ) 2 O 4 ] crystals, called magnetosomes, which enable magnetospirilla and other MTB to orient themselves along the Earth's magnetic field lines to find growth-favoring anoxic or microoxic zones within their aquatic habitats. Early Mössbauer spectroscopic and electron microscopic analyses indicated that crystallization of magnetite in Magnetospirillum magnetotacticum proceeds via precursors, including a ferritin-like ferrihydrite component (12). Using X-ray absorption near-edge structure (XANES) and high-resolution transmission electron microscopy (TEM), Fdez-Gubieda et al. (13) reported that magnetite is also rapidly biomineralized from a ferritin-like ferrihydrite precursor in Magnetospirillum gryphiswaldense MSR-1. An investigation on M. magneticum revealed the presence of a highly disordered and phosphate-rich ferric hydroxide phase consistent with prokaryotic ferritins outside the magnetosome vesicle (14). Interestingly, in this study the authors could show that this iron mineral phase transforms via purely inorganic ferrihydrite-like nanometric ferric(oxyhydr)oxides to magnetite within the magnetosomes (14). Based on Mössbauer spectroscopic analyses of MSR-1, however, a magnetite biomineralization model without mineral precursor phases was suggested (15). Nevertheless, it was proposed that a ferritin-like compound is required for the release of iron at the magnetosomecompartment interface (15). Preliminary biochemical analyses provided evidence that the ferritin-like ferrihydrite metabolite is of proteinaceous and not inorganic origin (15). The authors could enrich a reddish, high-molecular-mass protein (M Ͼ 100 kDa) that carried large amounts of iron. However, the ferritin-like component has not been identified at the molecular level yet.
In order to identify the ferritin-like iron metabolite and clarify its role for magnetite biomineralization, we started to analyze ferritin-like proteins of MSR-1. Using genetic, biochemical, and spectroscopic techniques, we show that, contrary to previous assumptions, ferritin-like proteins are not required for magnetite biomineralization but involved in the resistance to oxidative stress. We also provide evidence that Bfr of MSR-1 is a heterotetraeicosameric protein complex consisting of subunits with distinct biochemical and catalytic properties. Furthermore, we show that the Bfr1 subunit requires interaction with Bfr2 to form stable nanocages.

RESULTS
Eleven genes encoding proteins with at least partial homology to eight different ferritin-like subfamilies were identified in the genome of MSR-1 (16 Fig. S1A in the supplemental material). Among these, Bfr1 and Bfr2 first caught our attention since both proteins are encoded by genes that are separated by only 11 nt and seem to form a bicistronic operon (Fig. S1B). Furthermore, sequence analyses revealed the lack of a Met residue at position 52 in Bfr1 which is essential for axial heme binding at subunit interfaces (17). Thus, Bfr1 is likely unable to contribute to heme binding. In contrast, several residues of the FC are mutated in Bfr2 (Fig. S1C). These findings suggested that the Bfr proteins of MSR-1 are functionally divergent and might form a heterooligomeric bacterioferritin complex. To test if Bfr1 and Bfr2 indeed interact, a bacterial two-hybrid assay was performed. Therefore, bfr1 and bfr2 were cloned in frame with either the N-terminal T25 domain or the C-terminal T18 domain of the Bordetella pertussis CyaA adenylate cyclase, respectively. The resulting T18 and T25 plasmids were cotransformed into Escherichia coli BTH101 in different combinations with empty pUT18c and pKNT25 vectors as controls. Protein-protein interactions were evaluated after growth of spotted cell suspensions on LB-X-Gal-IPTG plates. While all control strain colonies remained white, strains coexpressing T18-bfr1 and bfr1-T25 or T18-bfr2 and bfr2-T25 formed dark blue colonies, indicating strong self-interactions (Fig. 1A). Interestingly, we also observed a strong interaction in strains coexpressing T18-bfr1 and bfr2-T25, indicating a Bfr heterooligomerization. In contrast, strains coexpressing T18-bfr2 and bfr1-T25 revealed no interaction, which, however, might have been caused by sterical hindrance of the T-domains in a heterooligomeric Bfr complex. To confirm the formation of heterooligomeric nanocages in vivo, we next aimed to purify the native protein complex from MSR-1. Unfortunately, various attempts employing classical (heat treatment, butanol extraction, and anion-exchange and size exclusion chromatography [AEC and SEC, respectively]) or recombinant (affinity purification of tagged Bfr) methods were not successful due to the low abundance of the protein, its temperature sensitivity, or its strong tendency to aggregate. Hence, we coexpressed bfr1 and bfr2 in E. coli. After purification of Bfr by SEC and AEC, four bands were observed on SDS-PAGE: two intense bands at approximately 15 kDa and 18 kDa and two faint bands of 12 and 36 kDa, respectively (Fig. 1B). The small 12-kDa band was attributed to a degradation product because its concentration increased concomitantly to the length of the expression period and was recognized by an anti-Bfr1 antibody. Edman sequencing of the 15-kDa band revealed sequences perfectly matching the N terminus of Bfr1, whereas the sequence from the 18-kDa band was identical to the first 10 aa of Bfr2. For the band at 36 kDa, a 20-aa-long sequence that had 100% identity to Bfr2 could be determined. In contrast to the band at 18 kDa, the 36-kDa band was also stained in immunoblots with anti-Bfr1 antibodies (Fig. 1B), further indicating formation of a heterooligomeric Bfr. However, the presence of two different homooligomers of the same molecular weight (MW) could still not be excluded using SEC and AEC. Therefore, we changed our strategy and used Strep tag affinity purification to isolate Strep-tagged Bfr1. By this method, Bfr2 could be copurified and was present at a similar ratio as Bfr1 as observed with SEC/AEC-purified untagged Bfr (Fig. 1C). Subsequent purification of His-tagged Bfr2 using Ni-NTA affinity chromatography resulted in the removal of the ϳ12-kDa degradation product, whereas Bfr1 and Bfr2 were still present at similar ratios, indicating that the two proteins were present in the same complex (Fig. 1C). Next, purified Bfr extracts were loaded onto a blue native (BN)-PAGE gel to determine the MW of the complex. This analysis revealed the presence of two distinct bands of ϳ500 kDa and ϳ740 kDa, respectively (Fig. 1D). While these results suggested the presence of two different Bfr complexes, 2D-BN/SDS-PAGE analyses revealed that Bfr1 and Bfr2 were present in both high-MW bands (Fig. 1E). Since it is well known that vertebrate ferritins can form dimers (18) and horse spleen ferritin was also separated into a 450-kDa monomeric nanocage band and a 720-kDa dimeric nanocage band (Fig. 1D), we assume that the 740-kDa band of MSR-1 Bfr also reflects a dimeric Bfr nanocage fraction. Subsequently, we used transmission electron microscopy (TEM) to estimate the number of subunits of a single Bfr nanocage. The analysis of negatively stained protein complexes revealed an average outer diameter of 11.87 Ϯ 1.02 nm (Fig. S2). Almost-identical complex sizes of 11.95 Ϯ 0.76 nm were observed with tetraeicosameric horse spleen ferritin, which suggested that also Bfr of MSR-1 is composed of 24 subunits.
Next, we were interested in the role of iron-storing ferritins for magnetite biomineralization and generated unmarked deletion mutants of dps and the bfr12 operon. TEM analyses showed that both mutants formed magnetite crystals with an average diameter of 33 Ϯ 9.7 nm (Δbfr12) or 32.4 Ϯ 8.3 nm (Δdps) that were essentially identical to the WT (34.8 Ϯ 10.2 nm). Also, the average numbers of magnetosomes (Δbfr12 ϭ 33.1 Ϯ 8.5 cell Ϫ1 ; Δdps ϭ 34.1 Ϯ 11.1 cell Ϫ1 ) were similar to the WT 34.3 Ϯ 8.4 cell Ϫ1 (Fig. S3), indicating that in both mutants magnetosome formation was not affected. To exclude the possibility that Dps and Bfr complement each other in terms of magnetite biomineralization, we aimed to delete bfr12 in the dps mutant background. Under microaerobic conditions (2% O 2 ), only a few clones that still contained the bfr genes were obtained. However, under strictly anoxic conditions we succeeded in the generation of the dps/bfr12 double deletion mutant, suggesting that growth of the dps/bfr12 mutant might be inhibited by oxygen. Thus, we analyzed magnetosome formation of the dps/bfr12 mutant after growth under anoxic conditions. Unexpectedly, we failed to detect any significant difference from the WT with respect to magnetic response (WT ϭ 1.42 Ϯ 0.01 versus ⌬dps/bfr12 ϭ 1.4 Ϯ 0.03), magnetosome numbers (WT ϭ 28.2 Ϯ 8.0 cell Ϫ1 versus Δdps/bfr12 ϭ 28.8 Ϯ 8.1 cell Ϫ1 ) as well as magnetite crystal diameters (WT ϭ 41.0 Ϯ 11.4 nm versus Δdps/bfr12 ϭ 39.6 Ϯ 12.0 nm) or crystal shape ( Fig. 2A to D). Also, magnetosome induction experiments by addition of iron to cells grown under iron-limiting conditions revealed no differences between the WT and Δdps/bfr12 strains. In both strains, the magnetic response started to increase already 30 min after iron induction (Fig. 2E) and reached saturation 2 h postinduction, indicating that the ferritin-like proteins Dps and Bfr are not required for magnetite formation in MSR-1.
Previous studies suggested that a bacterioferritin-like protein corresponds to the conspicuous ferritin-like iron metabolite implicated in magnetosome formation (12)(13)(14)(15). To test this assumption, the WT and Δbfr12 strains were grown in the presence of 40 M 57 Fe(citrate) 2 , harvested in late logarithmic growth phase, and subjected to whole-cell transmission Mössbauer spectroscopic (TMS) analysis at 130 K (above the Verwey temperature of magnetite [T V ϭ 113 K]). In spectra of the WT, three iron metabolites could be detected based on their Mössbauer parameters (isomer shift [␦], quadrupole splitting] ΔE Q ], and hyperfine field [Bhf]) ( Table 1, subspectra 1 to 4). The major component exhibits two magnetically split sextets typical of magnetite sites A and B (Fig. 3, s2 and s3, respectively). The second component was attributed to a ferrihydrite-like ferric high-spin species (s4) which is a marker for ferritin-like species. Evidence for this classification follows from a comparison of Mössbauer spectra from MSR-1 WT and the magnetite-free ΔmamM mutant measured at 130 and 4.2 K (19) ( Table 1, s8 to s11). A minor doublet in the WT spectrum was attributed to a ferrous high-spin iron [Fe 2ϩ O 6 (X 6 ) n ] nϪ10 metabolite (Fig. 3, s1). In Δbfr12 cells, again, magnetite was identified as the main iron metabolite (Fig. 3, s6 and s7). In addition, a minor doublet component (Fig. 3, s5) belongs to a [Fe 4 -S 4 ] 2ϩ protein (19,20), which is masked or not present in the WT. However, no ferrihydrite-like component (i.e., ferric high-spin species) was traceable in TMS spectra of the Δbfr12 mutant. These Mössbauer experiments substantiate that the ferrihydrite signal is caused by the iron mineral core of Bfr and that biosynthesis of magnetite does not require Bfr.
Since the dps/bfr12 double deletion mutant could be generated only under anaerobic conditions, we suggested that Bfr might be involved in the resistance to oxidative Bfr Is Not Involved in Magnetite Biomineralization ® stress. To confirm this assumption, we tested MSR-1 WT, Δdps, Δbfr12, Δdps/bfr12, and corresponding transcomplemented mutant strains for susceptibility to oxidative stress ( Fig. 4A and B). Under oxic conditions (21% O 2 ), the mutant Δdps (ϩ3.6 Ϯ 0.6 h; two-tailed t test, P value ϭ 0.0039), Δbfr12 (ϩ3.3 Ϯ 0.7 h, P value ϭ 0.0054), and Δdps/ bfr12 (ϩ6.0 Ϯ 0.8 h, P value ϭ 0.0002) strains showed significantly prolonged lag phases compared to the WT (20.9 Ϯ 0.3 h). Transcomplementation of the mutant strains with dps or bfr12 partially restored the growth delay. However, lag phases of the Δbfr12ϩbfr1 and Δbfr12ϩbfr2 transcomplementation strains were almost similar to that of the noncomplemented Δbfr12 mutant. In the presence of O 2 and H 2 O 2 , the duration of the lag phase of the WT increased to 24.7 Ϯ 0.6 h. Whereas the lag phase duration of the Δbfr12 mutant was also moderately increased, strains with a dps deletion showed strikingly prolonged lag phases relative to the WT (Δdps ϭ ϩ16.9 Ϯ 3.5 h; Δdps/bfr12 ϭ ϩ30.8 Ϯ 0.9 h). Transcomplementation of Δdps and Δdps/bfr12 strains with dps restored lag-phase duration to WT or Δbfr12 levels, respectively. In contrast, transcomplementation of the Δdps/bfr12 mutant with bfr12 had a much weaker effect and reduced the lag phase by only 8 h to ϩ22.8 Ϯ 1.3 h relative to the WT. While these results confirmed our suggestion that Bfr is involved in the resistance to oxidative stress, it remained unclear why the Bfr1 subunit, containing the FC but lacking heme binding residues, was not able to complement the bfr12 mutant. Previous studies showed that the catalytic activity of Bfr does not depend on heme but requires the FC (17,21). To analyze Bfr1 in more detail, we overexpressed single bfr genes and bfr12 in E. coli. After cell harvest, we already noted differences in the color of the cell pellets of the expression strains: while cell pellets of strains expressing bfr2 or bfr12 had a slightly reddish color, bfr1 expression strains formed beige cell pellets (Fig. S4). We speculated that this difference is related to the heme-binding capability of the expressed subunit(s). Thus, after affinity purification we employed a pyridine hemochrome assay to determine the heme content of Bfr and the single subunits ( Fig. 5A and B). Difference spectra of reduced and oxidized Bfr12 yielded a peak at 557 nm which indicated the presence of heme b (22), if also in very small amounts (0.24 to 0.6 heme b molecules per tetraeicosamer). Slightly lower heme contents were observed with Bfr2 (ϳ0.12 molecules per tetraeicosamer), while no heme could be detected in Bfr1 samples, confirming our initial assumption that Bfr1 is unable to bind a Summary of parameters used to fit the spectra of Fig. 3 and of spectra not shown in this contribution. b Line with largest full width at half maximum. c A ferrous iron metabolite with similar Mössbauer characteristics has been observed in many bacterial and fungal systems and was identified as cytoplasmic oligomeric ferrous sugar phosphate in E. coli (39). d Data taken from reference 40: spectra document superparamagnetic transitions between 77 and 4.2 K, yielding complete magnetically split species indicating iron mineral cores as in mammalian ferritins.
heme. Next, the catalytic activities of the bacterioferritins were determined. The heterooligomeric Bfr12 showed the highest activity, whereas both single Bfr subunits revealed iron oxidation rates that were only slightly above the autoxidation control (Fig. 5C). While the low catalytic activities of Bfr1 or Bfr2 explain why they were unable to restore the lag-phase duration of the Δbfr12 mutant under aerobic conditions, it remained unclear why Bfr1 had such low activities. We thus subjected the single subunits and Bfr12 to BN-PAGE to analyze their oligomeric states. These experiments revealed that Bfr12 (500 and 740 kDa) and Bfr2 (550 kDa) mainly formed high-MW oligomers whereas in the Bfr1 sample only a minor fraction of higher oligomers (500 kDa) and a large fraction of ϳ58 kDa (corresponding to trimers) was observed (Fig. 5D). Consistent with these observations, Bfr2 homooligomeric nanocages with a diameter of 12.16 Ϯ 0.76 nm could be readily observed by TEM while Bfr1 samples contained no or only few nanocage-like structures with a diameter of 13.09 Ϯ 0.84 nm (Fig. S2). These results indicate that Bfr1, in the absence of Bfr2, fails to efficiently assemble into a functional Bfr complex and explains why expression of bfr1 alone was unable to complement the ⌬bfr12 mutant. To finally prove that Bfr1 and Bfr2 have distinct functions and that the catalytic activity of Bfr12 is based on the FC of Bfr1, we analyzed the ferroxidase activity of a Bfr12 version in which the FC mutations of Bfr2 were introduced into Bfr1 (E18Q, H54A, and H131M). As expected, FC-negative Bfr12 . Similar metabolites are indicated by similar colors (yellow, blue, turquoise, red, and green, respectively). For details and parameters used to fit metabolite spectra, see Table 1.

Bfr Is Not Involved in Magnetite Biomineralization
® showed drastically reduced iron oxidation rates compared to WT Bfr12 and heme-free Bfr12(M52L) (Fig. 5E and F).

DISCUSSION
In this study, we identified and characterized ferritin-like proteins from MSR-1 to analyze their role during magnetite biomineralization. In contrast to previous reports, which proposed a central role for a ferritin-like component in the magnetite biomineralization pathway (12-15), we were unable to detect any defects or alterations during magnetite biomineralization in the Δdps, Δbfr12, and Δdps/bfr12 ferritin-like mutants. Thus, neither bacterioferritin nor Dps are required for magnetite formation in MSR-1. While it might be possible that other, so-far-uncharacterized, ferritin-like proteins encoded in the genome of MSR-1 are required for magnetite biomineralization, our data indicate that Bfr is identical to the ferritin-like component identified in earlier studies, since ferritin-like signals were absent from the Δbfr12 strain. Therefore, we propose that magnetite biomineralization in MSR-1 is independent of ferritin-like proteins. Furthermore, our results suggest that previous studies, which implicated ferritin-like ferrihydrite in the magnetite biomineralization pathway, simply failed to spatially resolve the independent biomineralization reactions within bacterioferritin and magnetosomes.
Unlike most bacteria with characterized bacterioferritins, MSR-1 contains two distinct bfr genes (bfr1 and bfr2) organized in a putative bicistronic operon. Similar organizations have so far been found only in Neisseria gonorrhoeae (23) and M. magnetotacticum (24), while distinct bfr genes of cyanobacteria (25) and fluorescent pseudomonads (26) are dispersed in their genomes. Although these studies already suggested the existence of heterooligomeric nanocages, direct evidence that isolated Bfr proteins were located within the same protein complex, and did not represent two different homooligomers, was lacking (23)(24)(25)(26). In contrast, using SDS-PAGE analyses of tandem-affinity-purified Bfr, bacterial two-hybrid analysis, and (2D)-BN-PAGE as well as TEM imaging, we could for the first time unequivocally show the formation of a heterooligomeric bacterioferritin consisting of 24 subunits.
Consistent with its phylogenetic affiliation with the Bfr subfamily, heme b was detected in purified Bfr, although at a very low concentration. While similarly low heme contents have been described for Bfr from E. coli upon unbalanced overexpression (27), we could show that Bfr1, in contrast to Bfr2, is unable to contribute to heme binding, Growth inhibition is expressed as lag-phase duration difference of ferritin-like mutants and transcomplementation strains relative to the WT. Lag-phase duration difference was calculated by measuring the time to grow to an OD 565 of 0.1 for each strain and subtracting the time that the WT required to grow to the same OD 565 . Values are given as means from at least 4 independent replicates Ϯ standard error of the mean. *, P Ͻ 0.05 in two-tailed t test; ns, no significant difference (P Ն 0.05 in two-tailed t test). most likely due to the lack of Met52, which is required for axial heme binding between the subunits (17). According to the weaker Bfr2 band intensities relative to those of Bfr1 in SDS-PAGE and 2D-BN-PAGE experiments, we suggest that heterotetraeicosameric nanocages have an unequal Bfr1:Bfr2 subunit stoichiometry of 14:10. Thus, MSR-1 Bfr may contain at maximum five heme b binding sites per nanocage, which corresponds to only ϳ60% of the heme-binding capacity of Bfr from E. coli and most likely also contributes to the low heme content of isolated Bfr. Considering the proposed role of heme in facilitating the release of iron from the mineral core (21), and the increased Bfr Is Not Involved in Magnetite Biomineralization ® iron content of heme-free compared to heme-containing Bfr in E. coli (17), heterooligomeric Bfrs with only a few heme-binding sites could have evolved to store increased amounts of iron. This might be supported by the fact that heteroligomeric Bfrs have mainly been proposed for organisms with relatively high iron demand (e.g., magnetotactic, photosynthetic, or pathogenic bacteria) (23)(24)(25). Furthermore, the reduced number of FCs per oligomer may also contribute to an increased iron storage capability since L-rich ferritins from liver or spleen have been found to incorporate much more iron than H-rich ferritins from heart muscle or brain cells (28).
In contrast to heme binding, residues essential for the ferroxidase activity are conserved in Bfr1 only, since in Bfr2 several ferroxidase site residues are mutated. However, despite the presence of an FC, Bfr1 extracts showed unexpectedly low ferroxidase activities. We suggest that the low catalytic activity of Bfr1 is mainly based on the small amount of Bfr1 homooligomers. This would also be consistent with the finding that expression of bfr1 alone could not restore the growth of the Δbfr12 mutant under aerobic conditions. Interestingly, also other organisms, for which a heterooligomeric Bfr has been proposed, seem to require both subunits to assemble functional Bfr complexes. For example, in Synechocystis sp. strain PCC 6803, it was observed that upon deletion of bfrB (corresponding to Bfr2 from MSR-1), no oligomeric complexes composed of BfrA (corresponding to Bfr1 of MSR-1) could be isolated (25). Similarly, despite the presence of bfrA, no iron-containing oligomers could be detected in N. gonorrhoeae ΔbfrB mutants (23). While the structural basis of the poor Bfr1 oligomerization remains to be elucidated, sequence analyses suggest that several exchanges of residues critical for oligomerization of E. coli Bfr (K33E, Y45E, D56G, E60N, and E128Q) (29) prevent proper assembly.
With Bfr2, we obtained almost equally low ferroxidase activities as observed with Bfr1. However, in contrast to Bfr1, the majority of Bfr2 was found to be assembled as an oligomer. Thus, the low ferroxidase activity can be directly related to the absence of the FC. This idea is also supported by the low activity of Bfr12 in which the Bfr2 FC mutations were introduced into Bfr1 (E18Q, H54A, and H131M). Thus, the high activity of the heterooligomeric MSR-1 Bfr is mainly caused by the FC of properly assembled Bfr1.
In summary, we showed that in contrast to several previous reports the ferritin-like proteins Bfr and Dps are not involved in magnetite biomineralization. Additionally, we have characterized a heterotetraeicosameric bacterioferritin with, similar to vertebrate ferritins, functionally distinct subunits.

MATERIALS AND METHODS
Strains, plasmids, and growth conditions. Bacterial strains and plasmids are described in Text S1 in the supplemental material. E. coli strains were grown in lysogeny broth (LB) supplemented with kanamycin (25 g ml Ϫ1 ) or ampicillin (50 g ml Ϫ1 ) at 37°C with vigorous shaking (200 rpm). For cultivation of E. coli BW29427, LB was supplemented with DL-␣,-diaminopimelic acid (1 mM). All MSR-1 strains were grown at 28°C or 30°C in modified flask standard medium (FSM) with moderate agitation (120 rpm) under aerobic, microaerobic, or anaerobic conditions (30). To obtain 57 Fe-enriched cells for Mössbauer spectroscopic analysis, iron was removed from glassware by three washing steps with 25% (wt/vol) HCl, followed by three rinses with 1/2-volume deionized water. MSR-1 cells were then cultivated in FSM supplemented with 40 M 57 Fe(citrate) 2 (31).
Molecular and genetic techniques. Unless specified otherwise, molecular techniques were performed using standard protocols (32). All oligonucleotide primers (Text S1) were purchased from Sigma-Aldrich.
Point mutations were generated using the Phusion site-directed mutagenesis kit (Thermo Scientific). Generation of MSR-1 mutants. For the generation of unmarked MSR-1 dps and bfr deletion mutants, ϳ0.7-kb fragments of the up-and downstream regions of dps and bfr12 were amplified by PCR using Phusion polymerase (New England BioLabs [NEB]) (primers [Text S1]). After gel purification of PCR products, the corresponding up-and downstream fragments were fused by overlap extension PCR with T4 polynucleotide kinase (Thermo Scientific) phosphorylated primers. The fused PCR products were subsequently cloned into dephosphorylated EcoRV-digested pORFM-GalK vector to yield pORFM⌬dps and pORFM⌬bfr12, respectively. Deletion vectors were transferred to MSR-1 by conjugation as described previously (33). Kanamycin-resistant plasmid insertion mutants were isolated after incubation for 5 days (30°C, 1.5% O 2 ), transferred to 100 l fresh FSM, and grown overnight (30°C, 1.5% O 2 ). One-hundredmicroliter cultures were then inoculated into 900 l fresh FSM and incubated for 24 h at 30°C and 1.5% O 2 before 100 l cell culture was plated on FSM agar plates containing 2.5% galactose and 100 ng l Ϫ1 Uebe et al. ® anhydrotetracycline (34). After incubation for 5 days (30°C, 1.5% O 2 ), mutant colonies were PCR verified and transferred to 100 l FSM. For deletion of bfr12 in the ⌬dps mutant, counterselection on FSM galactose plates was performed by incubation for 14 days under anaerobic conditions at ambient temperature using a Coy anaerobic chamber.
Oxidative stress sensitivity assay. To test growth of MSR-1 in the presence of O 2 and/or H 2 O 2 , the WT, mutant, and pBam1-transcomplemented mutant strains (Table S1) were passaged three times in 3 ml FSM (without antibiotics) overnight at 28°C with 2% O 2 . Cultures were then diluted to an OD 565 of 0.1 in FSM, and 100 l of diluted cultures was used to inoculate 900 l FSM containing 10 M H 2 O 2 (Merck). Aerobic growth (21% O 2 ) at 141 rpm and 28°C was monitored every 20 min at 565 nm with an Infinite 200pro microplate reader (Tecan) for 80 h.
Determination of Bfr heme content. Heme contents were determined by a pyridine hemochrome assay (35). Reduced minus oxidized difference spectra were recorded to identify heme groups. Heme concentrations were calculated applying a differential extinction coefficient, 557-540nm ϭ 22.1 M Ϫ1 cm Ϫ1 (35).
N-terminal Edman sequencing. Purified Bfr12 was electroblotted on a PVDF membrane and stained with freshly prepared 0.1% Coomassie R-250 (in 40% methanol) and 1% acetic acid for 30 s. Destaining was performed with 50% methanol until the background was clear and bands were visible. The membrane was air dried, bands were cut, and N-terminal Bfr subunit amino acid sequences were determined by Edman degradation.

BN-PAGE and 2D-BN/SDS-PAGE analyses.
To separate proteins by their native MW, we used 6 to 12% or 6 to 15% polyacrylamide gradient gels for BN-PAGE analyses as described previously (36). Therefore, Bfr12 samples were dialyzed against 50 mM imidazole-HCl, 50 mM NaCl, pH 7, at 4°C overnight (Visking type 8/32; MW cutoff [MWCO], 14 kDa [Carl Roth]). Alternatively, Bfr2 and Bfr1 plus -2 protein samples were adjusted to a concentration of 4.5 mg ml Ϫ1 in buffer A1 and diluted by addition of 50 mM Tris-HCl, pH 8.0, and 10ϫ BN-PAGE loading buffer (50% [wt/vol] glycerol, 0.1% [wt/vol] Ponceau S) to a final concentration of 450 g ml Ϫ1 (ϳ22 M) protein, 5% (wt/vol) glycerol, and 0.01% (wt/vol) Ponceau S in 50 mM Tris-HCl, 50 mM NaCl, pH 8.0. Bfr1 samples were adjusted to a concentration of 6 mg ml Ϫ1 in buffer A1 and then diluted to a final concentration of 600 g ml Ϫ1 (ϳ30 M) protein, 5% (wt/vol) glycerol, and 0.01% (wt/vol) Ponceau S in 50 mM Tris-HCl, 50 mM NaCl, pH 8.0. Of these samples, 30 l was loaded onto BN-PAGE gels with 10 l of native marker liquid mix (Serva) as a control. The gels were then run at 4°C, 100 V, and 15 mA. After the run front reached one-third of the total run, the cathode buffer B (7.5 mM imidazole, 50 mM Tricine, 0.02% [wt/vol] Coomassie brilliant blue G-250) was replaced with cathode buffer B/10 (7.5 mM imidazole, 50 mM Tricine, 0.002% [wt/vol] Coomassie brilliant blue G-250), and the run was continued until the run front reached the end of the gel. BN-PAGE gels were then stained with Coomassie brilliant blue R-250 or subjected to 2D-BN/SDS-PAGE analysis.
For 2D-BN/SDS-PAGE, lanes of interest were cut out from BN-PAGE gels, briefly heated in 1% (wt/vol) SDS with 10 mM DTT, and equilibrated for 20 min. Treated gel strips were then clamped between glass plates of a gel casting apparatus, and an 8 to 22.5% gradient separation gel was poured underneath the gel strips. After polymerization, a 5% stacking gel was cast below the gel strip. After 4 l PageRuler prestained protein ladder (Thermo Scientific) and 1 g SDS-treated sample of the same protein from the first dimension were loaded, the SDS-PAGE gels were run at 25 mA per gel and 300 V for 3 h at room temperature (RT). Subsequently, gels were stained with Coomassie brilliant blue R-250.
Determination of ferroxidase activities. For the measurement of the ferroxidase activity, 1 M Bfr was incubated with 150 M FeCl 2 in a total volume of 200 l at 27°C, and the absorbance at 310 nm was measured over a period of 200 s (Evolution 201 UV-Vis spectrophotometer; Thermo Scientific). For this purpose, 178 l of 50 mM MOPS, 50 mM NaCl, pH 7, mixed with 20 l of 10 M respective Bfr was used as a reference, and the reaction was started by the addition of 2 l of 15 mM FeCl 2 solution. As a negative control, 20 l of buffer A1 was added instead of Bfr.
Transmission Mössbauer spectroscopy. For TMS analyses, MSR-1 WT, ⌬mamM, and ⌬bfr12 strains were grown in 57 Fe-enriched medium and harvested at late exponential phase. Cell pellets were weighed, transferred into Delrin Mössbauer sample holders, frozen in liquid nitrogen, and kept at this temperature and in part at Ϫ80°C until measurement except for overnight transport on dry ice. The Mössbauer spectra were recorded in the horizontal transmission geometry using a constant acceleration spectrometer operated in conjunction with a 512-channel analyzer in the time scale mode. The detector consisted of a proportional counter filled with argon-methane (9:1). The source was at room temperature and consisted of 0.7 to 0.2 GBq [ 57 Co] diffused in Rh foil (WissEl). The spectrometer was calibrated against ␣-iron at room temperature (RT). For measurements at 130 and 77 K, samples were placed in a continuous-flow cryostat (Oxford Instruments). For measurements at 4.2 K, a helium bath cryostat (MD306; Oxford Instruments) was employed. The 57 Co source exhibiting an activity of 0.19 GBq was sealed in an Rh matrix at RT and was mounted on a constant-velocity drive. The detector consisted of a proportional counter made in-house and filled with argon-methane (90:10). Spectral data were buffered in a multichannel analyzer and transferred to a PC for further analysis, employing the Vinda program on an Excel 2003 platform (37). Isomer shifts ␦, quadrupole splittings ΔE Q and Bhf, and percentages of the total absorption area were obtained by least-squares fits of Lorentzian lines to the experimental spectra.
Transmission electron microscopy. For TEM analysis, unstained cells were concentrated, adsorbed onto carbon-or Pioloform-coated copper grids, and washed two times with ddH 2 O (38). For TEM of Bfr and horse spleen ferritin samples, protein solutions were adsorbed on a carbon-coated copper grid for 10 min. Then, the grid was incubated for 3 min on uranyl acetate (2% [wt/vol]) for negative contrast and washed with ddH 2 O once. Bright-field TEM was performed on an FEI Tecnai F20 (FEI) or Zeiss EM902A (Zeiss) transmission electron microscope using an accelerating voltage of 200 kV or 80 kV, respectively. For data processing, interpretation, and analysis, the software packages DigitalMicrograph (Gatan) and ImageJ (NIH) were used. For determinations of magnetite particle numbers per cell, at least 100 cells were analyzed and at least 450 particles were measured for analysis of magnetite particle diameters. For determination of Bfr and ferritin diameters, at least 100 particles were analyzed.